Results 111 to 120 of about 356 (173)
Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study. [PDF]
Nunome H +11 more
europepmc +1 more source
Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study. [PDF]
Ujihara N +11 more
europepmc +1 more source
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial. [PDF]
Zhou J +20 more
europepmc +1 more source
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. [PDF]
EMPA-KIDNEY Collaborative Group +41 more
europepmc +1 more source
Tokenism and Its Long-Term Consequences: Evidence from the Literary Field. [PDF]
Childress C, Nayyar J, Gibson I.
europepmc +1 more source

